OZYMF.US
id: 735
Orphazyme A/S (ORPH) $2.5M IPO Settlement
N.D. Illinois
Court1:21-CV-03640
Case number29 Sept 2020
Class period Start04 Nov 2021
Class period End17 Jan 2024
Claim deadlineOrphazyme A/S (ORPH) agreed to settle $2.5 million with investors to end claims over misleading statements during its IPO in 2020.
Case Status
Disbursement
Alleged Offence
Misleading Statements,
Failure to Disclose,
Omissions
Suspected Party
Directors,
Management
Security Type
Depository Securities (ADS, ADR, GDR)
Trade Direction
Long
Payout per Share
0.12
Filing date
09 July 2021
Plaintiffs
Marko Busic
Attorneys
Bronstein, Gewirtz & Grossman, LLC (New York, NY), Pomerantz LLP (Chicago, IL)
Defendants
Christophe Bourdon, Anders Vadsholt, Kim Stratton, Thomas Blaettler, Molly Painter, Georges Gemayel, Bo Jesper Hansen, Martin Bonde, Rémi Droller, Sten Verland, Martijn Kleijwegt, Anders Hedegaard, Catherine Moukheibir, Carrolee Barlow
Judge
Hon. John F. Kness
Administrator
A.B. Data Ltd
Settlement agreement date
2023-05-12
Trades matching type
FIFO
Disbursement date
20 September 2024
+$2,500,000
Cash Settlement Amount